Myofibroblasts and apoptosis in human hypertrophic scars: The effect of interferon-α2b

Surgery

Volumn 130, Issue 5, 2001, Pages 798-808

  Nedelec, Bernadette ^a   Shankowsky, Heather ^a   Scott, Paul G ^a   Ghahary, Aziz ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA2B INTERFERON; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; MALE; MORBIDITY; MYOFIBROBLAST; NICK END LABELING; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT PLANNING; WOUND HEALING;

EID: 0034750624     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.116453     Document Type: Article

References (43)

1. Hypertrophic scars, keloids and contractures. The cellular and molecular basis for therapy
2. Impairment, time out of school, and time off from work after burns
3. Serial casting as a technique to correct burn scar contractures
4. Evaluation of various methods of treating keloids and hypertrophic scars: A 10-year follow up study
5. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction
6. Morphological and immunochemical differences between keloid and hypertrophic scar
7. A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation
8. Transforming growth factor-β in thermally injured patients with hypertrophic scars: Effects of interferon α-2b
9. Selective inhibition of human diploid fibroblast collagen synthesis by interferons
10. Expression of fibronectin messenger RNA in hypertrophic and normal dermal tissues and in vitro regulation by interferon alfa-2b
11. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblast in vitro by interferon-γ
12. Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alfa-2b
13. Interferons gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts
14. Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma
15. The effect of interferon-α2b on the expression of cytoskeletal proteins in an in vitro model of wound contraction
16. Suppression of in vitro proliferative scar fibroblast contraction by interferon alfa-2b
17. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan and collagenase production in vitro
18. A controlled trial of intralesional recombinant interferon-γ in the treatment of keloidal scarring
19. Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren’s disease: An open pilot study
20. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing
21. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
22. Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells
23. Characteristics of granulation tissue which promote hypertrophic scarring
24. Natural human interferon-α augments apoptosis in activated T cell line
25. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2
26. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α
27. Rating the burn scar
28. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
29. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonized by interferon-α and interferon-γ in vitro and in vivo
30. Histologic basis of keloid and hypertrophic scar differentiation
31. The histiotypic organization of the hypertrophic scar in humans
32. Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human post-burn hypertrophic scar tissues
33. Transforming growth factor β1 induces α-smooth muscle actin expression in granulation tissue myofibroblast and in quiescent and growing cultured fibroblasts
34. Rating the resolving hypertrophic scar: Comparison of the Vancouver scar scale and scar volume
35. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-β in human post-burn hypertrophic and mature scars
36. Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars
37. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury
38. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes
39. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar
40. The effect of interferon-α2b on guinea pig wound closure and the expression of cytoskeletal proteins in vivo
41. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
42. Myofibroblast and their role in lung collagen gene expression during pulmonary fibrosis
43. Subcutaneous tissue fibroblast transfected with muscle and nonmuscle actins: A good in vitro model to study fibroblastic cell plasticity